{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:28:03Z","timestamp":1792481283397,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Parapneumonic pleural effusion and pleural empyema (PPE\/PE) are complications of community-acquired pneumonia. The objective of this study was to analyze prehospital antibiotic therapy (PH-ABT) of children with PPE\/PE and investigate its effects on clinical outcome and pathogen detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Prospective nationwide active surveillance in Germany between October 2010 and June 2018. Children and adolescents &lt;18 years of age with pneumonia-associated PE or PPE requiring drainage or with persistence of PPE\/PE &gt;7 days were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 1724 children with PPE\/PE were reported, of whom 556 children (32.3% of 1719 with available data) received PH-ABT. Children with PH-ABT had a shorter median hospital length of stay (15 vs. 18 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), a longer time from onset of symptoms until hospital discharge (25 vs. 23 days,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002), a lower rate of intensive care unit admission (58.3% vs. 64.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015) and fewer infectious complications (5.9% vs. 10.0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005). Bacterial pathogens in blood or pleural fluid culture were detected in 597 (34.5%) of 1513 children. Positive culture results were less frequent in children with than without PH-ABT (81\/466 [17.4%] vs. 299\/1005 [29.8%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), whereas detection rates in pleural fluid samples by polymerase chain reaction were similar (91\/181 [50.3%] vs. 220\/398 [55.3%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.263).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In children with PPE\/PE, PH-ABT significantly reduced the overall rate of bacterial pathogen detection by culture, but not by polymerase chain reaction. PH-ABT was associated with a lower rate of infectious complications but did not affect the overall duration of disease. We therefore speculate that the duration of PPE\/PE is mainly a consequence of an infection-induced inflammatory process, which can only partially be influenced by antibiotic treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000003036","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T02:00:12Z","timestamp":1609725612000},"page":"544-549","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Effect of Prehospital Antibiotic Therapy on Clinical Outcome and Pathogen Detection in Children With Parapneumonic Pleural Effusion\/Pleural Empyema"],"prefix":"10.1097","volume":"40","author":[{"given":"Johannes","family":"Forster","sequence":"first","affiliation":[{"name":"University of Wuerzburg, Institute of Hygiene and Microbiology, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goettler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kemmling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schoen","sequence":"additional","affiliation":[{"name":"University of Wuerzburg, Institute of Hygiene and Microbiology, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rose","sequence":"additional","affiliation":[{"name":"Klinikum Stuttgart, Olgahospital- Pediatric Pulmonology, Stuttgart, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Streng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Liese","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Hospital of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,28]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.arcped.2011.05.010","article-title":"[Parapneumonic pleural effusion incidence in a French region before and during the antipneumococcal vaccine era].","volume":"18","author":"Masson","year":"2011","journal-title":"Arch Pediatr"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study.","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States.","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2014-306525","article-title":"Has the incidence of empyema in Scottish children continued to increase beyond 2005?","volume":"100","author":"Nath","year":"2015","journal-title":"Archives Disease Childhood"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1651-2227.2011.02290.x","article-title":"Parapneumonic empyema in children before the era of pneumococcal vaccination.","volume":"100","author":"Niemi","year":"2011","journal-title":"Acta Paediatr"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/INF.0000000000001798","article-title":"Pneumococcal vaccination and pneumonia associated with pleural effusion in a pediatric population.","volume":"37","author":"Bernaola","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/00365540802688378","article-title":"Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine.","volume":"41","author":"Goldbart","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/502680","article-title":"Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids.","volume":"42","author":"Le Monnier","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/INF.0000000000001940","article-title":"Blood culture and pleural fluid culture yields in pediatric empyema patients: a retrospective review, 1996-2016.","volume":"37","author":"Stankey","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2334-8-90","article-title":"Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.","volume":"8","author":"Nyambat","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2016.05.009","article-title":"Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.","volume":"116","author":"Krenke","year":"2016","journal-title":"Respir Med"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1469-0691.2011.03632.x","article-title":"Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.","volume":"18","author":"Obando","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ppul.23562","article-title":"Therapy of 645 children with parapneumonic effusion and empyema-a German nationwide surveillance study.","volume":"52","author":"Segerer","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jpedsurg.2016.02.047","article-title":"Trends in treatment of infectious parapneumonic effusions in U.S. children\u2019s hospitals, 2004-2014.","volume":"51","author":"Dorman","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpedsurg.2017.07.017","article-title":"Evolution of practice in the management of parapneumonic effusion and empyema in children.","volume":"53","author":"Griffith","year":"2018","journal-title":"J Pediatr Surg"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jinf.2017.01.009","article-title":"Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.","volume":"74","author":"Amaro","year":"2017","journal-title":"J Infect"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41479-018-0047-4","article-title":"The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study.","volume":"10","author":"Chakrabarti","year":"2018","journal-title":"Pneumonia (Nathan)"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"O531","DOI":"10.1111\/1469-0691.12524","article-title":"Impact of pre-hospital antibiotic use on community-acquired pneumonia.","volume":"20","author":"Simonetti","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ppul.23523","article-title":"Complicated community acquired pneumonia in childhood: different types, clinical course, and outcome.","volume":"52","author":"Erlichman","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"suppl 2","key":"R27-20250615","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2011-200598","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011.","volume":"66","author":"Harris","year":"2011","journal-title":"Thorax"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/AAC.17.2.199","article-title":"Absorption and disposition kinetics of amoxicillin in normal human subjects.","volume":"17","author":"Arancibia","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20250615","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/25.4.645","article-title":"Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.","volume":"25","author":"Lang","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"R30-20250615","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets.","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"R33-20250615","first-page":"CD005437","article-title":"Pre-admission antibiotics for suspected cases of meningococcal disease.","volume":"6","author":"Sudarsanam","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/INF.0b013e318170b678","article-title":"Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.","volume":"27","author":"Chiu","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1183\/09031936.95.08081352","article-title":"Fibrinolytic and inflammatory processes in pleural effusions.","volume":"8","author":"Philip-Jo\u00ebt","year":"1995","journal-title":"Eur Respir J"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial.","volume":"185","author":"Tagarro","year":"2017","journal-title":"J Pediatr"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/2014\/757963","article-title":"Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children.","volume":"25","author":"Pernica","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3182002d14","article-title":"Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema.","volume":"30","author":"Blaschke","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1073\/pnas.122244799","article-title":"A critical concentration of neutrophils is required for effective bacterial killing in suspension.","volume":"99","author":"Li","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/adc.2003.042176","article-title":"Empyema: the use of broad range 16S rDNA PCR for pathogen detection.","volume":"90","author":"Saglani","year":"2005","journal-title":"Arch Dis Child"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"R43-20250615","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10096-006-0225-9","article-title":"Pneumolysin polymerase chain reaction for diagnosis of pneumococcal pneumonia and empyema in children.","volume":"25","author":"Lahti","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:01:11Z","timestamp":1749988871000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,28]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003036","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,28]]}}}